Cargando…

Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia

Background: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterizied by elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) which is an important source of substrates to be oxidized by different oxidative agents. Subsequently, the oxidized LD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganjali, Shiva, Keshavarz, Reihaneh, Hosseini, Susan, Mansouri, Atena, Mannarino, Massimo R., Pirro, Matteo, Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707741/
https://www.ncbi.nlm.nih.gov/pubmed/34945165
http://dx.doi.org/10.3390/jcm10245867
_version_ 1784622511416147968
author Ganjali, Shiva
Keshavarz, Reihaneh
Hosseini, Susan
Mansouri, Atena
Mannarino, Massimo R.
Pirro, Matteo
Jamialahmadi, Tannaz
Sahebkar, Amirhossein
author_facet Ganjali, Shiva
Keshavarz, Reihaneh
Hosseini, Susan
Mansouri, Atena
Mannarino, Massimo R.
Pirro, Matteo
Jamialahmadi, Tannaz
Sahebkar, Amirhossein
author_sort Ganjali, Shiva
collection PubMed
description Background: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterizied by elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) which is an important source of substrates to be oxidized by different oxidative agents. Subsequently, the oxidized LDLs (oxLDLs) induce further oxidative reactions in FH patients, which contributes to the development of atherosclerosis and advanced cardiovascular events in these patients. This study aimed to investigate the association of oxidant/antioxidant markers with FH. Methods: This case-control study comprised 18 HoFH, 18 HeFH, and 20 healthy subjects. Oxidant/antioxidant markers including MDA, MPO, thiol, nitric oxide (NO), myeloperoxidase (MPO), glutathione peroxidase (GPx), SOD, and CAT were assessed by colorimetric methods. Prooxidant-antioxidant balance was also measured by pro-oxidant antioxidant balance (PAB) assay. Results: The levels of MDA (p < 0.001), MPO activity (p < 0.001), thiol (p < 0.001), NO (p < 0.01), and PAB (p < 0.001) were notably higher in HoFH group in comparison with healthy subjects. HeFH group also showed significantly higher levels of thiol (p < 0.001) and PAB (p < 0.001) when compared to healthy subjects. Elevated levels of MDA (p < 0.001) and PAB (p < 0.001) were also observed in HoFH relative to HeFH. No significant differences were found between the studied groups in the case of antioxidant enzyme activities. The results of binary logistic regression showed that PAB (OR: 0.979; p = 0.033), and MDA (OR: 0.996; p = 0.018) levels were inversely associated with HoFH, although, after adjustment for age and LDL-C levels, these associations were diminished. Conclusion: Several oxidant/antioxidant differences were found between FH patients and healthy individuals as well as between HoFH and HeFH patients. These differences might be strongly dependent on plasma LDL-C levels.
format Online
Article
Text
id pubmed-8707741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87077412021-12-25 Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia Ganjali, Shiva Keshavarz, Reihaneh Hosseini, Susan Mansouri, Atena Mannarino, Massimo R. Pirro, Matteo Jamialahmadi, Tannaz Sahebkar, Amirhossein J Clin Med Article Background: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterizied by elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) which is an important source of substrates to be oxidized by different oxidative agents. Subsequently, the oxidized LDLs (oxLDLs) induce further oxidative reactions in FH patients, which contributes to the development of atherosclerosis and advanced cardiovascular events in these patients. This study aimed to investigate the association of oxidant/antioxidant markers with FH. Methods: This case-control study comprised 18 HoFH, 18 HeFH, and 20 healthy subjects. Oxidant/antioxidant markers including MDA, MPO, thiol, nitric oxide (NO), myeloperoxidase (MPO), glutathione peroxidase (GPx), SOD, and CAT were assessed by colorimetric methods. Prooxidant-antioxidant balance was also measured by pro-oxidant antioxidant balance (PAB) assay. Results: The levels of MDA (p < 0.001), MPO activity (p < 0.001), thiol (p < 0.001), NO (p < 0.01), and PAB (p < 0.001) were notably higher in HoFH group in comparison with healthy subjects. HeFH group also showed significantly higher levels of thiol (p < 0.001) and PAB (p < 0.001) when compared to healthy subjects. Elevated levels of MDA (p < 0.001) and PAB (p < 0.001) were also observed in HoFH relative to HeFH. No significant differences were found between the studied groups in the case of antioxidant enzyme activities. The results of binary logistic regression showed that PAB (OR: 0.979; p = 0.033), and MDA (OR: 0.996; p = 0.018) levels were inversely associated with HoFH, although, after adjustment for age and LDL-C levels, these associations were diminished. Conclusion: Several oxidant/antioxidant differences were found between FH patients and healthy individuals as well as between HoFH and HeFH patients. These differences might be strongly dependent on plasma LDL-C levels. MDPI 2021-12-14 /pmc/articles/PMC8707741/ /pubmed/34945165 http://dx.doi.org/10.3390/jcm10245867 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ganjali, Shiva
Keshavarz, Reihaneh
Hosseini, Susan
Mansouri, Atena
Mannarino, Massimo R.
Pirro, Matteo
Jamialahmadi, Tannaz
Sahebkar, Amirhossein
Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title_full Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title_fullStr Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title_full_unstemmed Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title_short Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
title_sort evaluation of oxidative stress status in familial hypercholesterolemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707741/
https://www.ncbi.nlm.nih.gov/pubmed/34945165
http://dx.doi.org/10.3390/jcm10245867
work_keys_str_mv AT ganjalishiva evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT keshavarzreihaneh evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT hosseinisusan evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT mansouriatena evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT mannarinomassimor evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT pirromatteo evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT jamialahmaditannaz evaluationofoxidativestressstatusinfamilialhypercholesterolemia
AT sahebkaramirhossein evaluationofoxidativestressstatusinfamilialhypercholesterolemia